Obezite Cerrahisi ile Zayıflama

Op. Dr. Murat Üstün ve ekibi tarafından sunulan tüp mide, gastrik bypass gibi obezite cerrahisi prosedürleri ve tamamlayıcı tedavilerle obeziteyi hayatından çıkaran binlerce hastamızın arasına katılın.

Randevu Alın
Op. Dr. Murat Üstün
Obezite İlaçları

Shocking Rise in US Obesity Rates: CDC Report Reveals Alarming Results Despite Ozempic and GLP-1 Medications

The latest data from the US Centers for Disease Control and Prevention (CDC) paints a sobering picture: despite the meteoric rise of GLP-1 receptor agonist medications like Ozempic, Wegovy, and Mounjaro, obesity rates in the United States continue to climb at alarming rates. This disconnect between pharmaceutical innovation and population-level outcomes has important implications for the role of bariatric surgery in obesity treatment.

Key Findings of the CDC Report

The 2026 CDC National Health and Nutrition Examination Survey (NHANES) report reveals several disturbing trends that challenge the narrative that weight-loss medications alone can solve the obesity epidemic.

Adult Obesity Data

The overall adult obesity rate has reached 42.4%, continuing its steady upward trajectory. More concerning is that severe obesity (BMI ≥ 40) has climbed to 9.7% — nearly 1 in 10 American adults. This is particularly significant because severe obesity is associated with the highest rates of comorbidities including type 2 diabetes, cardiovascular disease, sleep apnea, and certain cancers.

Record Increase in Childhood Obesity

Perhaps the most alarming finding is in pediatric obesity rates. Childhood obesity has increased across all age groups:

  • Ages 2-5: 14.3% obesity rate (up from 12.7%)
  • Ages 6-11: 22.4% obesity rate (up from 20.7%)
  • Ages 12-19: 24.6% obesity rate (up from 22.2%)

These numbers are particularly concerning because childhood obesity is a strong predictor of adult obesity and its associated health complications.

Gender Differences: Higher Increase in Women

The data shows notable gender disparities. The female adult obesity rate has risen to 44.7%, while the male rate stands at 40.3%. The rate of severe obesity is also higher among women (11.5%) compared to men (7.8%). These differences may reflect hormonal, socioeconomic, and lifestyle factors.

Why Are Ozempic and GLP-1 Medications Not Enough?

Despite their proven efficacy in clinical trials, GLP-1 receptor agonists face several real-world limitations:

  • Cost and accessibility: Monthly costs of $1,000-1,500 make them inaccessible to many patients
  • Adherence challenges: Studies show 50-70% of patients discontinue within 12 months
  • Weight regain: Up to 2/3 of lost weight is regained within one year of stopping
  • Side effects: Nausea, vomiting, and gastrointestinal issues affect 30-40% of patients
  • Muscle mass loss: 25-40% of weight lost may come from lean muscle mass
  • Population reach: Only 3-5% of eligible patients are currently using these medications

Bariatric Surgery: A Lasting and Proven Solution

In contrast to medications that require lifelong use and show diminishing returns, bariatric surgery offers durable, long-term results backed by decades of evidence.

Advantages of Bariatric Surgery

  • Sustained weight loss: 60-80% excess weight loss maintained at 10+ years
  • Diabetes remission: 80-90% complete remission of type 2 diabetes
  • Cardiovascular improvement: 50% reduction in cardiovascular mortality
  • Cancer risk reduction: 30-40% lower risk of obesity-related cancers
  • Quality of life: Significant improvements in mobility, mental health, and overall wellbeing
  • Life expectancy: Average increase of 3-5 years in severely obese patients

Who Is a Suitable Candidate?

Bariatric surgery is recommended for patients with:

  • BMI ≥ 40 (severe obesity)
  • BMI ≥ 35 with obesity-related comorbidities (diabetes, hypertension, sleep apnea)
  • BMI 30-35 with poorly controlled type 2 diabetes (metabolic surgery)
  • Failed attempts at sustained weight loss through diet, exercise, and/or medications

Bariatric Surgery in Turkey

Turkey has become one of the leading destinations for bariatric surgery, offering world-class surgical expertise at competitive prices. Op. Dr. Murat Üstün, with over 21 years of experience and 8,000+ successful operations at Liv Hospital Istanbul, performs the full spectrum of bariatric procedures including sleeve gastrectomy, gastric bypass, mini gastric bypass, and revision surgeries using the latest robotic and minimally invasive techniques.

Conclusion: Medications Are Not Enough — Comprehensive Treatment Is Needed

The CDC data clearly demonstrates that no single approach — including the much-heralded GLP-1 medications — can address the obesity epidemic alone. A comprehensive strategy combining lifestyle modifications, medical management, and surgical intervention when appropriate remains the gold standard for lasting weight management and metabolic health improvement.

If you are struggling with obesity and its related health conditions, bariatric surgery may offer the lasting solution you need. Contact Op. Dr. Murat Üstün for a free initial consultation.